We are live on ! Find out more
KZIA

Kazia Therapeutics
KZIA

17 hedge funds and large institutions have $2.24M invested in Kazia Therapeutics in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more capital invested

Capital invested by funds: $236K → $2.24M (+$2M)

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

89% more funds holding

Funds holding: 9 → 17 (+8)

0.03% more ownership

Funds ownership: 0% → 0.04% (+0.03%)

Holders
17
Holders Change
+8
Holders Change %
+88.89%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
3
Reduced
1
Closed
2
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$1.45M
2
PIM
Platinum Investment Management
Australia
+$1.07M
3
Morgan Stanley
Morgan Stanley
New York
+$125K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$82.1K
5
HSBC Holdings
HSBC Holdings
United Kingdom
+$58.7K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$199
2
VF
Virtu Financial
New York
-$117
3
SPIA
Steward Partners Investment Advisory
New York
-$25
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$1.09M +$1.45M +49,511 New
PIM
2
Platinum Investment Management
Australia
$801K +$1.07M +36,438 New
Morgan Stanley
3
Morgan Stanley
New York
$177K +$125K +4,263 +112%
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$65.9K +$82.1K +2,803 New
HSBC Holdings
5
HSBC Holdings
United Kingdom
$45.1K +$58.7K +2,004 New
TSS
6
Two Sigma Securities
New York
$25.7K +$34.2K +1,168 New
XT
7
XTX Topco
Cayman Islands
$8.73K +$11.4K +389 New
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$8K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$5.75K +$7.49K +256 New
BNP Paribas Financial Markets
10
BNP Paribas Financial Markets
France
$5.58K +$2.46K +84 +49%
VF
11
Virtu Financial
New York
$5K -$117 -4 -2%
RhumbLine Advisers
12
RhumbLine Advisers
Massachusetts
$4.36K +$1.26K +43 +28%
NA
13
NewEdge Advisors
Louisiana
$220 – – –
UBS Group
14
UBS Group
Switzerland
$44 +$59 +2 New
AF
15
Allworth Financial
California
$39 – – –
MSWM
16
McGlone Suttner Wealth Management
Wisconsin
$37 +$59 +2 New
AF
17
Advisornet Financial
Minnesota
$2 – – –
Bank of America
18
Bank of America
North Carolina
– -$199 -4 Closed
SPIA
19
Steward Partners Investment Advisory
New York
– -$25 -1 Closed
Simplex Trading
20
Simplex Trading
Illinois
– +$117 +4 New

KZIA Hedge Fund Activity: Q4 2023 in Review

17 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q4 2023, worth a combined $2.24M — up 850% from $236K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new KZIA positions and 2 closed out — a net gain of 8 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.45M. The largest seller was Bank of America, exiting entirely with an estimated $199 sold.

  • 17 institutional investors held Kazia Therapeutics (KZIA) as of Q4 2023, up from 9 in Q3 2023.
  • Funds reported $2.24M of Kazia Therapeutics stock for Q4 2023, up 850% quarter-over-quarter.
  • 10 funds opened new Kazia Therapeutics positions in Q4 2023 and 2 closed out, a net change of +8 holders.
  • The largest Kazia Therapeutics buyer in Q4 2023 was Armistice Capital, an estimated $1.45M added.
  • The largest Kazia Therapeutics seller in Q4 2023 was Bank of America, an estimated $199 sold.

Based on aggregated 13F filings for Q4 2023.